The market performance of EyePoint Pharmaceuticals Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $30.99 on 02/08/24, with the lowest value for the same timeframe being $4.45, recorded on 04/19/23.
52-week price history of EYPT Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. EyePoint Pharmaceuticals Inc’s current trading price is -38.69% away from its 52-week high, while its distance from the 52-week low is 327.45%. The stock’s price range for this period has remained between $4.45 and $30.99. The Healthcare sector company’s shares managed to surpass a trading volume of around 2.4 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.93 million over the last three months.
Financial Performance and Market Capitalization
EyePoint Pharmaceuticals Inc (EYPT) has experienced a quarterly decline of -16.89% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 946.77M and boasts a workforce of 121 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 22.33, with a change in price of +13.22. Similarly, EyePoint Pharmaceuticals Inc recorded 1,373,964 in trading volume during the last 100 days, posting a change of +220.33%.
EYPT Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for EYPT stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
EYPT Stock Stochastic Average
As of today, the raw stochastic average of EyePoint Pharmaceuticals Inc over the past 50 days is 15.75%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 31.65%. Additionally, the Stochastic %K and %D values for the company were 39.58% and 45.36%, respectively, over the past 20 days.
EYPT Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price decrease of -17.78%. However, over the past six months, we’ve seen a weaker performance of 136.32%. The price of EYPT leaped by -14.03% over the last 30 days. And in the last five days, it has fallen by -16.99%.
